• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Glucagon-like peptide-1 receptor agonists are associated with reduced risk of developing substance use disorders

bySiwen Liu, MScandSimon Pan, MD
March 9, 2026
in Chronic Disease, Endocrinology, Pharma
Reading Time: 2 mins read
Diabetes collage: a lidded sugar bowl inside a blue paper circle, with a whole apple and a bunch of leafy greens
Share on FacebookShare on TwitterShare on LinkedIn

1. Use of glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced risk of developing substance use disorders among US veterans with type 2 diabetes.

Evidence Rating Level: 2 (Good)

Glucagon-like peptide-1 (GLP-1) receptor agonists have been associated with reduced risks of incident substance use disorders (SUDs) such as alcohol use and incident cannabis use disorder. However, the link between GLP-1 receptor agonists and risks of other SUDs, such as opioid use disorder and stimulant use disorder are unclear. This study thus investigated the relationship between initiation of GLP-1 receptor agonists and risk of incident SUDs across a range of substances in people with no history of SUDs. This cohort study emulated a set of eight parallel, new user target trials using the US Department of Veterans Affairs electronic health records and included veterans aged >18 and a diagnosis of type 2 diabetes. Participants were assigned to one of the two protocols: people without pre-existing SUD in protocol 1 and people with pre-existing SUD in protocol 2. For both protocols, treatment strategies of initiating a GLP-1 receptor agonist versus a sodium-glucose cotransporter-2 (SGLT-2) inhibitor were compared. Patients were followed for up to three years. The main outcomes of incident SUDs were alcohol, cannabis, cocaine, nicotine, opioid, other SUDs, and a composite of these outcomes. Out of the 524,817 participants included in Protocol 1, 124,001 initiated GLP-1 receptor agonists and or 400,816 initiated SGLT-2 inhibitors. Out of the 81,617 participants included in Protocol 2, 16,768 initiated GLP-1 receptor agonists, and 64,849 initiated SGLT-2 inhibitors. Compared with initiation of SGLT-2 inhibitors, initiation of GLP-1 receptor agonists was associated with 18% lower risk of alcohol use disorders (hazard ratio [HR], 0.8295%; 95% CI, 0.78 to 0.85), 14% lower risk of cannabis use (HR, 0.86; 95% CI, 0.81 to 0.90), 20% lower risk of cocaine use (HR, 0.80; 95% CI, 0.72 to 0.88), 20% lower risk of nicotine use (HR, 0.80; 95% CI, 0.74 to 0.87), 25% lower risk of opioid use (HR, 0.75; 95% CI, 0.67 to 0.85), 13% lower risk of other SUDs (HR, 0.87; 95% CI, 0.81 to 0.94), and 14% lower risk of composite outcome of all incident SUDs (HR, 0.86; 95% CI, 0.83 to 0.88). Overall, this study found that initiating GLP-1 receptor agonists was associated with reduced risk of developing various SUDs, highlighting its potential in the prevention of SUDs. 

Click here to read this study in the BMJ (British Medical Journal)

FDA approvedFor type 2 diabetes: Onswik (insulin efsitora alfa-gobe), Sep 23, 2026→

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Post-traumatic stress disorder is associated with increased risk of mild cognitive impairment and dementia among United States Veterans

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

Tags: endocrinologyglucagon-like peptide-1 (GLP-1) receptor agonistssubstance use disorderType 2 Diabetes Mellitusveterans
Previous Post

Oral infigratinib boosts growth velocity in achondroplasia study

Next Post

Shingles vaccine and sildenafil linked to lower Alzheimer’s risk

RelatedReports

A senior woman is depicted alongside images of a brain, a magnifying glass, a test tube, and playing cards, suggesting cognitive assessment related to dementia.
Chronic Disease

Post-traumatic stress disorder is associated with increased risk of mild cognitive impairment and dementia among United States Veterans

October 2, 2026
Physical activity collage: a smiling middle-aged man in a track jacket beside a city bicycle and a teal resistance band
Chronic Disease

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

September 2, 2026
Atrial fibrillation collage: an engraved heart with teal upper chambers, paper sparks and a dotted teal ribbon around it
Weekly Rewinds

2 Minute Medicine Rewind August 31, 2026

August 31, 2026
Optic nerve damage collage: an engraved eyeball in side view with light rays entering the pupil and a teal optic nerve
Endocrinology

Swedish study reports low vision loss risk with GLP-1RAs

July 13, 2026
Next Post
Shingles collage: an engraved spine and ribcage with one nerve traced in teal, a blank vaccine vial and a folded cloth

Shingles vaccine and sildenafil linked to lower Alzheimer’s risk

Physical activity collage: an engraved bicycle, a water bottle lying on its side and a path of flat stepping stones

Visual perturbation training may be superior to treadmill training for reduction of fall risk in Parkinson's disease

Recovery after surgery collage: an older man in a hospital gown under an operating lamp, small walking scenes and a wristband

Lower preoperative serum calcium is associated with increased risk of postoperative complications in patients undergoing orthopedic surgery

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Less social media usage is associated with improved internalizing symptoms in high-risk young adults.
  • AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality
  • In a phase 3 trial, tirzepatide reduced BMI versus placebo in adolescents with obesity and obesity-related complications
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.